Senseonics Holdings (SENS) EBITDA Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | -4,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,868.00 |
| Dec 31, 2025 | 4,074.00 |
| Sep 30, 2025 | 32,100.00 |
| Jun 30, 2025 | 19,940.00 |
| Mar 31, 2025 | 14,591.00 |
| Dec 31, 2024 | 2,654.00 |
| Sep 30, 2024 | -16,713.00 |
| Jun 30, 2024 | 7,546.00 |
| Mar 31, 2024 | -41,692.00 |
| Dec 31, 2023 | -43,010.00 |
| Sep 30, 2023 | 91,351.00 |
| Jun 30, 2023 | -7.64 Mn |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -45,826.00 |
| Sep 30, 2022 | -1.69 Mn |
| Jun 30, 2022 | 11.75 Mn |
| Mar 31, 2022 | 3.83 Mn |
| Dec 31, 2021 | 329,090.00 |
| Sep 30, 2021 | 1.86 Mn |
| Jun 30, 2021 | -3.88 Mn |
| Mar 31, 2021 | 12.86 Mn |
| Dec 31, 2020 | -221,826.00 |
| Sep 30, 2020 | -260,303.00 |
| Jun 30, 2020 | -220,482.00 |
| Mar 31, 2020 | -13.65 Mn |
| Dec 31, 2019 | -29,588.00 |
| Sep 30, 2019 | 16,662.00 |
| Jun 30, 2019 | 22,244.00 |
| Mar 31, 2019 | -10,183.00 |
| Dec 31, 2018 | 45,759.00 |
| Sep 30, 2018 | 21,067.00 |
| Jun 30, 2018 | 62,321.00 |
| Mar 31, 2018 | 160,797.00 |
| Dec 31, 2017 | 305,140.00 |
| Sep 30, 2017 | 2.86 Mn |
| Jun 30, 2017 | 6.09 Mn |
| Sep 30, 2016 | -683,222.00 |
| Jun 30, 2016 | -3.24 Mn |